US Patent 11090377 Avian reovirus vaccines
Patent 11090377 was granted and assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+504 characters)
Article
Patent abstract
The present invention relates to novel strains of avian reovirus that were isolated from clinical cases of viral arthritis/tenosynovitis in chickens in the southeast United States. The invention is directed to these novel group 1 and group 2 avian reoviruses, diagnostic assays using antibodies and/or nucleotide- or amino acid-specific components of such viruses, such as the S1 gene encoding the sigma C protein, and to vaccines that protect chickens from disease caused by such viruses.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110903770
Date of Patent
August 17, 2021
0Patent Application Number
201911140
Date Filed
November 14, 2019
0Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110903770
Date of Patent
August 17, 2021
0Patent Application Number
201911140
Date Filed
November 14, 2019
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11090377 Avian reovirus vaccines
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11090377
Date of patent
August 17, 2021
Patent application number
20191114
Date Filed
November 14, 2019
Find more entities like US Patent 11090377 Avian reovirus vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
